Atlas Trials

A Study to Test the Long-term Safety of BI 655130 in Patients With Atopic Eczema Who Took Part in Study 1368-0032

Clinical trial NCT04086121 · TERMINATED

Trial details

NCT number
NCT04086121
Sponsor
Boehringer Ingelheim
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Dermatitis, Atopic
Start date
2019-09-24
Primary completion
2021-04-28
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.